Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Proteomic Analysis of Therapeutic Biomarkers to Guide Treatment in Patients with Bone Metastasis
Yeoun Jin Kim
Nantomics

DescriptionY/NSource
Grantsno
SalaryyesNantOmics
Board Memberno
Stockyes NantOmics
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes